HK1012423A1 - Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase - Google Patents

Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase

Info

Publication number
HK1012423A1
HK1012423A1 HK98113498A HK98113498A HK1012423A1 HK 1012423 A1 HK1012423 A1 HK 1012423A1 HK 98113498 A HK98113498 A HK 98113498A HK 98113498 A HK98113498 A HK 98113498A HK 1012423 A1 HK1012423 A1 HK 1012423A1
Authority
HK
Hong Kong
Prior art keywords
preparation
formula
pharmaceutically acceptable
pharmaceutically active
oxazolidine compounds
Prior art date
Application number
HK98113498A
Other languages
English (en)
Inventor
Richard Mark Hindley
Stefan Roland Woroniecki
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1012423A1 publication Critical patent/HK1012423A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
HK98113498A 1991-11-19 1998-12-15 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase HK1012423A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919124513A GB9124513D0 (en) 1991-11-19 1991-11-19 Novel process
PCT/GB1992/002140 WO1993010254A1 (en) 1991-11-19 1992-11-19 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase

Publications (1)

Publication Number Publication Date
HK1012423A1 true HK1012423A1 (en) 1999-07-30

Family

ID=10704843

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113498A HK1012423A1 (en) 1991-11-19 1998-12-15 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase

Country Status (19)

Country Link
US (2) US5726055A (xx)
EP (2) EP0905255A3 (xx)
JP (1) JP3782099B2 (xx)
KR (2) KR100270133B1 (xx)
AT (1) ATE181114T1 (xx)
AU (3) AU673145B2 (xx)
CA (1) CA2123782A1 (xx)
DE (1) DE69229402T2 (xx)
DK (1) DK0615549T3 (xx)
ES (1) ES2132135T3 (xx)
GB (1) GB9124513D0 (xx)
GR (1) GR3031029T3 (xx)
HK (1) HK1012423A1 (xx)
MX (1) MX9206679A (xx)
NZ (1) NZ245182A (xx)
PT (1) PT101077B (xx)
TW (1) TW240249B (xx)
WO (1) WO1993010254A1 (xx)
ZA (1) ZA928937B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
GB9723295D0 (en) 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
US7091359B2 (en) 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
DE69834508T2 (de) * 1997-11-19 2006-11-23 Takeda Pharmaceutical Co. Ltd. Apoptoseinhibitoren
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
AP1598A (en) 1999-04-23 2006-04-26 Smithkline Beecham Plc Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl) amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt.
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
EP1173434B1 (en) 1999-04-23 2003-08-20 SmithKline Beecham plc Thiazolidinedione derivative and its use as antidiabetic
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0021865D0 (en) * 2000-09-06 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0023971D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
GB0023970D0 (en) * 2000-09-29 2000-11-15 Smithkline Beecham Plc Novel pharmaceutical
EP1291436A1 (en) * 2001-09-11 2003-03-12 Bayer Ag Process for the stereoselective preparation of functionalized vicinal diols
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
WO2012153312A1 (en) 2011-05-11 2012-11-15 Ranbaxy Laboratories Limited Process for the purification of pioglitazone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
DE3001303A1 (de) * 1980-01-16 1981-07-23 Basf Ag, 6700 Ludwigshafen Optisch aktive phenylpropan-derivate, ihre herstellung und verwendung
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
DK173350B1 (da) * 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
US4857468A (en) * 1985-04-13 1989-08-15 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for preparing optically active 2-halo-1-phenyl ethanol
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
US5232925A (en) * 1987-09-04 1993-08-03 Beecham Group P.L.C. Compounds
US5143930A (en) * 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use

Also Published As

Publication number Publication date
JP3782099B2 (ja) 2006-06-07
ZA928937B (en) 1994-03-17
KR20070108290A (ko) 2007-11-09
NZ245182A (en) 1995-09-26
US20020106762A1 (en) 2002-08-08
WO1993010254A1 (en) 1993-05-27
AU673145B2 (en) 1996-10-31
KR100270133B1 (ko) 2000-10-16
DE69229402T2 (de) 1999-11-25
EP0905255A3 (en) 1999-04-14
DE69229402D1 (de) 1999-07-15
EP0615549A1 (en) 1994-09-21
DK0615549T3 (da) 1999-11-15
GR3031029T3 (en) 1999-12-31
CA2123782A1 (en) 1993-05-27
PT101077A (pt) 1994-02-28
AU6572896A (en) 1996-12-12
PT101077B (pt) 2000-09-29
ATE181114T1 (de) 1999-06-15
TW240249B (xx) 1995-02-11
JPH07503129A (ja) 1995-04-06
AU8954098A (en) 1999-01-14
ES2132135T3 (es) 1999-08-16
EP0905255A2 (en) 1999-03-31
MX9206679A (es) 1993-05-01
GB9124513D0 (en) 1992-01-08
US5726055A (en) 1998-03-10
AU2949492A (en) 1993-06-15
EP0615549B1 (en) 1999-06-09

Similar Documents

Publication Publication Date Title
ZA928937B (en) Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
HUT53368A (en) Process for producing pyrazolo-pyridine derivatives and pharmaceutical compositions containing them
AU6128590A (en) Novel compounds
FI893467A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ES8302001A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
EP0270093A3 (en) Lactam derivatives, processes for the preparation thereof, pharmaceutical compositions comprising the same, and the use of such derivatives for the manufacture of a medicament having valuable therapeutic properties
IE820239L (en) Carbapenem derivatives
HUT55601A (en) Fungicide compositions containing oxethane derivatives as active components and process for producing the active components
EP0555479A4 (xx)
ATE125256T1 (de) Zwischenprodukte der mureidomycin-gruppe, ihre herstellung und verwendung.
HU913293D0 (en) Process for the production of pierazine derivatives and medical preparations containing them
HUT44268A (en) Process for preparing compounds with construction similar to antibiotic tan-749
EP0449011A3 (en) Stereoselective process for the preparation of 2-amino-ethanol derivatives having a central analgesic activity and intermediates thereof
HUT58080A (en) Process for producing imidazole derivatives
EP0022629A3 (en) 2-aminoethanol derivatives, their preparation and use in pharmaceutical compositions
ATE109454T1 (de) Catecholaminester.
AU1317688A (en) Benzoxazine derivatives and processes for preparation thereof
ES482083A1 (es) Un procedimiento para la preparacion de un derivado de teta-hidro-2h-benzo-c-pirrol.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20031119

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)